Prognostic significance of erythropoietin in pancreatic adenocarcinoma.

Prognostic significance of erythropoietin in pancreatic adenocarcinoma.

BACKGROUND: Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). METHODOLOGY: The clinico-pathological relevance of hemoglobin...

Full description

Bibliographic Details
Main Authors: Thilo Welsch, Stefanie Zschäbitz, Verena Becker, Thomas Giese, Frank Bergmann, Ulf Hinz, Shereen Keleg, Anette Heller, Bence Sipos, Ursula Klingmüller, Markus W Büchler, Jens Werner, Nathalia A Giese
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3148251?pdf=render

Internet

http://europepmc.org/articles/PMC3148251?pdf=render

Similar Items